Meng Li | Clinical Medicine | Best Medical Scientist Award

Published on by Health Scientists

Mr. Meng Li | Clinical Medicine | Best Medical Scientist Award 

professor | Dandong Central Hospital | China

Dr. Meng Li currently serves as a Teaching Secretary and Professor of General Surgery at China Medical University and is also affiliated with Dandong Central Hospital, the largest Grade-A general hospital in the Liaodong region. She earned her Ph.D. in Oncology from China Medical University, one of the leading medical universities in China. Her primary research focuses on digestive tract tumor surgery, hepatobiliary and pancreatic surgery, gastrointestinal oncology, and the comprehensive treatment of malignant tumors. Over the years, Dr. Li has contributed significantly to the medical research community, publishing seven SCI/Scopus-indexed papers, including works on predictive models for intraabdominal infections after radical gastrectomy, gene signatures in hepatocarcinoma prognosis, and gut microbiota’s role in urological cancers. Her research has accumulated over 47 citations and has advanced understanding in cancer surgery and molecular oncology. In recognition of her outstanding contributions, she received the First Prize of the Liaoning Province Science and Technology Progress Award in 2023. Dr. Li actively participates in collaborative projects, including two National Natural Science Foundation programs, and holds memberships in several professional bodies such as the Chinese Anti-Cancer Association and the Chinese Pancreatic Disease Society. She also serves as an Editorial Board Member of the Cancer Research Journal (CRJ), a guest editor for two scientific journals, and a review editor for others, reflecting her strong commitment to scientific advancement and peer review excellence. Her long-term goal is to deepen molecular insights into cancer and improve clinical outcomes through innovative surgical research. He has 213 citations from 17 documents with an h-index of 7.

Profiles: Scopus | ORCID

Publications

1. Feng, Y., Yang, J., Li, M., Tang, L., Sun, S., & Wang, Y. (2024). A Bayesian network for simultaneous keyframe and landmark detection in ultrasonic cine.

2. Li, Z.-W., Wu, J.-T., Bi, Y., Li, M.-M., Naseem, A., Pan, J., Guan, W., Hao, Z.-C., Kuang, H.-X., & Chen, Q.-S. (2024). A new triterpenoid saponin and a new natural saponin from the roots of Bupleurum scorzonerifolium Willd.

3. Yu, X., Feng, B., Wu, J., & Li, M. (2024). A novel anoikis-related gene signature can predict the prognosis of hepatocarcinoma patients.

4. Yu, X., Tang, W., Bai, C., Li, R., Feng, B., Wu, J., Guo, X., Chen, H., & Li, M. (2024). A predictive model for intraabdominal infection after radical gastrectomy in elderly patients.

5. Li, M., Zhang, X., Chen, K., Miao, Y., Xu, Y., Sun, Y., Jiang, M., Liu, M., Gao, Y., & Xue, X. (2024). Alcohol exposure and disease associations: A Mendelian randomization and meta-analysis on weekly consumption and problematic drinking.

Jian Feng | Clinical Medicine | Best Researcher Award

Published on by Health Scientists

Dr. Jian Feng | Clinical Medicine | Best Researcher Award

Doctor | The General Hospital of Western Theater Command | China

Dr. Jian Feng is an Attending Physician at the Intensive Care Unit of The General Hospital of Western Theater Command in Chengdu, Sichuan Province, China. He earned his medical degree and completed advanced training in critical care medicine, with a focus on sepsis, multiple organ failure, acute respiratory distress syndrome, and altitude sickness. Dr. Feng has led and participated in multiple provincial- and national-level research projects, including studies on ICU-acquired weakness, the role of curcumin in skeletal muscle preservation at high altitudes, and innovative interventions in critical care. He has published extensively, with over 11 SCI-indexed papers and numerous Chinese core journal articles as first or corresponding author, including high-impact works in Asian Journal of Surgery, Journal of Inflammation Research, and Frontiers in Cellular and Infection Microbiology. His contributions extend to medical innovation, holding multiple invention and utility model patents, and co-authoring the monograph Clinical Nutritional Therapy for Neurocritical Care. Dr. Feng has received recognition for his research and clinical excellence, including awards for innovation and translational medicine. Beyond his research, he serves as a reviewer for prestigious journals such as Heliyon and Medical Science Monitor, demonstrating his commitment to advancing scientific rigor and critical peer review in the field of critical care medicine. His work combines clinical expertise with innovative research, reflecting a dedication to improving patient outcomes and contributing to the scientific community at both national and international levels. He has 51 citations from 20 documents with an h-index of 4.

Profiles: Scopus | ORCID

Publications

1. Wang, M., Huang, B., Chen, J., Rui, Z., Li, J., Fang, S., Fan, L., Feng, J., & Li, F. (2025). Artificial intelligence and machine learning in the research and application status of ICU-acquired weakness.

2. Liu, J., Xu, Z., Luo, S., Bai, Y., Feng, J., & Li, F. (2024). Risk factors for ICU-acquired weakness in sepsis patients: A retrospective study of 264 patients.

3. Tan, J., Huang, B., Luo, S., Li, R., Hou, J., Zhang, R., Wang, L., Liu, Y., Li, F., & Feng, J. (2024). A rare case of severe pneumonia combined with septic shock caused by Nocardia amamiensis.

4. Luo, H., Feng, J., Xue, G., Zhang, Y., Li, Y., Huang, X., Chen, X., You, S., Dong, H., & Li, L. (2023). Comparative efficacy and acceptability of 12 phosphorus-lowering drugs in adults with hyperphosphatemia and chronic kidney disease: A systematic review and network meta-analysis.

5. Luo, S., Wang, L., Xu, Z., Liu, J., Zhang, W., Feng, J., & Li, F. (2023). Isolation, identification and biological characteristics of phage vB-KpnP1 for carbapenem-resistant Klebsiella pneumoniae.